Additional Oncotype DX Assay-Related Articles
|
|
Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
|
|
J Sparano, S Paik
|
|
J Clin Oncol
2008.28(5):721-728 .
|
|
|
|
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
|
|
L Harris, H Fritsche, R Mennel, L Norton, P Ravdin, S Taube, MR Somerfield, DF Hayes, RC Bast Jr.
|
|
J Clin Oncol
2007
|
|
|
|
Adjuvant Chemotherapy for Patients with Estrogen Receptor-Positive Breast Cancer
|
|
HJ Burstein, S Paik, P Ravdin, K Albain
|
|
ASCO Educational Book
2006
|
|
|
|
Roadmap for Developing and Validating Therapeutically Relevant Genomic Classifiers
|
|
R Simon
|
|
J Clin Oncol
2005.23(29):7332-7341.
|
|
|
|
Development and Clinical Utility of a 21-Gene Recurrence Score Prognostic Assay in Patients with Early Breast Cancer Treated with Tamoxifen
|
|
S Paik
|
|
Oncologist
2007.12(6):631-635.
|
|
|
|
Genotypic characterization of phenotypically defined triple-negative breast cancer
|
|
J. A. Sparano, L. J. Goldestin, B. H. Childs, S. Shak, S. Badve, F. L. Baehner
|
|
Abstract # 500
|
|
|
|
Molecular characterization of male breast cancer by standardized quantitative RTPCR analysis: First large genomic study of 347 male breast cancers compared to 82,434 female breast cancers.
|
|
S. Shak, G. Palmer, F. L. Baehner, C. Millward, D. Watson, G. W. Sledge
|
|
Abstract # 549
|
|
|
|
Biopsy Cavities in Breast Cancer Specimens: Impact on Quantitative RT-PCR Gene Expression Profiles and Recurrence Risk Assessment
|
|
FL Baehner, C Quale, C Pomeroy, D Cherbavaz, S Shak.
|
|
Abstract # 1574
|
|
|
|
GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer.
|
|
Sparano JA, Gray R, Goldstein LJ, Childs BH, Bugarini R, Rowley S, Baker J, Shak S, Badve S, Baehner FL, Perez EA, Shulman LN, Martino S, Sledge Jr. GW, Davidson
|
|
Abstract # 25
|
|
|
|
Quantitative gene expression analysis using Oncotype DX in ductal carcinoma in situ that is adjacent to invasive ductal carcinoma.
|
|
Baehner FL, Sangli C, Millward C, Cherbavaz D, Goddard A, Shak S Genomic Health, Inc, Redwood City, CA
|
|
Abstract # 2066
|
|
|
|
Evaluation of Tumor Gene Expression and K-Ras Mutations in FFPE Tumor Tissue as Predictors of Response to Cetuximab in Metastatic Colorectal Cancer
|
|
JB Baker, D Dutta, D Watson, T Maddala, S Shak, EK Rowinsky, L Xu, E Clark, DJ Mauro, S Khambata-Ford
|
|
Abstract #3512
|
|
|
|
Analysis of Revised Nottingham Tumor Grade Constitutive Components and Recurrence Free Interval in ECOG Breast Cancer Study E2197
|
|
FL Baehner, LJ Goldstein, R Gray, T Maddala, S Shak, GW Sledge, JA Sparano, S Badve
|
|
Abstract #82: Oral Presentation
|
|
|
|
Relationship Between Tumor Gene Expression and Recurrence in Patients with Stage II/III Colon Cancer Treated with Surgery + 5-FU/LV in NSABP C-06: Consistency of Results with Two Other Independent Studies
|
|
MJ O'Connell, G Yothers, S Paik, IC Lavery, JW Cowens, KM Clark-Langone, MLopatin, JR Hackett, FL Baehner, N Wolmark
|
|
Abstract #301: Poster Session
|
|
|
|
Gene Expression by Standardized Quantitative RT-PCR in the Special Histologic Subtypes of Estrogen Receptor-Positive Invasive Breast Cancer
|
|
FL Baehner, D Watson, JT Ballard, G Palmer, S Shak
|
|
Abstract #3028: Poster Session
|
|
|
|
Relationship Between Tumor Gene Expression and Recurrence in an Observational Cohort of Patients with Stage II/III Colon Cancer Treated with Surgery Only: Quantitative RT-PCR Assay of 375 Genes in Fixed Paraffin-Embedded (FPE) Tissue
|
|
I Lavery, J Hammel, J Cowens, K Clark-Langone, J Hackett, F Baehner, G Yothers, M OConnell, N Wolmark
|
|
Abstract #302: Poster Session
|
|
|
|
Association of Individual Genes with Risk of Relapse in Operable Breast Cancer: Analysis of E2197
|
|
JA Sparano, L Goldstein, B Childs, C Yoshizawa, S Shak, J Baker, S Rowley, N Davidson, S Badve, GW Sledge Jr., R Gray
|
|
Abstract #27
|
|
|
|
The Impact on the Recurrence Score Due to Patient Variation in the Quantitative Expression of Individual Genes or Gene Groups
|
|
D Watson, G Palmer, J Baker, S Shak
|
|
Abstract #6039: Poster Presentation
|
|
|
|
Relationship Between Proliferation Genes and Expression of Hormone and Growth Factor Receptors: Quantitative RT-PCR in 10,618 Breast Cancers
|
|
S Shak, FL Baehner, G Palmer, JT Ballard, J Baker, D Watson
|
|
Abstract #6111: Poster Presentation
|
|
|
|
Subtypes of Breast Cancer Defined by Standardized Quantitative RT-PCR Analysis of 10,618 Tumors
|
|
S Shak, FL Baehner, G Palmer, JT Ballard, J Baker, D Watson
|
|
Abstract #6118: Poster Presentation
|
|
|
|
Gene Expression Profiles in Formalin-Fixed, Paraffin-Embedded (FFPE) Core Biopsies Predict Docetaxel Chemosensitivity
|
|
JC Chang, A Makris, SG Hilsenbeck, JR Hackett, J Jeong, ML Liu, J Baker, K Sexton, CK Osborne, S Shak
|
|
Abstract #538: Poster Discussion
|
|
|
|
Relationship Between Tumor Gene Expression and Recurrence in Stage II/III Colon Cancer: Quantitative RT-PCR Assay of 757 Genes in Fixed Paraffin-Embedded (FPE) Tissue
|
|
MJ O’Connell, S Paik, G Yothers, JP Costantino, JW Cowens, KM Clark, J Baker, J Hackett, D Watson, N Wolmark
|
|
Abstract #3518: Poster Discussion
|
|
|
|
Multiple GSTM Gene Family Members Are Recurrence Risk Markers in Breast Cancer
|
|
M Kiefer, K Hoyt, J Hackett, MG Walker, J Baker
|
|
Abstract #3604: Poster Discussion
|
|
|
|
Use of Macrodissection in Multi-Gene RNA Analysis of Fixed Paraffin- Embedded Tumor Tissue
|
|
R Baehner, B Hiller, CY Kim, C Alexander, ML Liu, M Pho, D Dutta, J Jeong, A Nguyen, M Walker, M Cronin, J Baker, S Paik
|
|
Abstract #80
|
|
|
|
Strategies to Optimize Anti-Receptor Therapies
|
|
J Baselga
|
|
|
|
|